[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-336302-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-336302-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","zeb1-as1-mediates-bone-metastasis-through-targeting-mir-320bbmpr1a-axis-in-lung-cancer","ZEB1-AS1 mediates bone metastasis through targeting miR-320b/BMPR1A axis in lung cancer","","Objective: This study investigated the role and regulatory mechanism of the lncRNA ZEB1-AS1 in lung cancer–associated bone metastasis. Methods: ZEB1-AS1 and miR-320b levels were quantified by qRT-PCR. Cell viability, proliferation, migration, and invasion were assessed using CCK-8, colony formation, and Transwell assays, with EMT markers measured by western blot. In vivo mouse models evaluated subcutaneous tumor growth and metastatic bone tumors using H&E staining. Results: ZEB1-AS1 was upregulated and miR-320b downregulated in lung cancer. ZEB1-AS1 knockdown suppressed malignant phenotypes and EMT in A549 cells and confirmed targeting relationships with miR-320b and BMPR1A. Conclusion: ZEB1-AS1 mediates bone metastasis by regulating the miR-320b/BMPR1A axis.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/zeb1-as1-mediates-bone-metastasis-through-targeting-mir-320bbmpr1a-axis-in-lung-cancer/336302/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/zeb1-as1-mediates-bone-metastasis-through-targeting-mir-320bbmpr1a-axis-in-lung-cancer/336302.png","ImageObject",300,407,{"name":42,"@type":43},"Eliana","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-23","2026-09-21",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",10,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What is the main objective of this study?","Question",{"text":63,"@type":64},"To explore the role and regulatory mechanism of lncRNA ZEB1-AS1 in lung cancer–related bone metastasis.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How were ZEB1-AS1 and miR-320b levels measured?",{"text":68,"@type":64},"ZEB1-AS1 and miR-320b expression were determined by qRT-PCR.",{"name":70,"@type":61,"acceptedAnswer":71},"What key mechanism links ZEB1-AS1 to bone metastasis?",{"text":72,"@type":64},"ZEB1-AS1 targets miR-320b and regulates BMPR1A through the miR-320b/BMPR1A axis, influencing cell viability, proliferation, migration, invasion, and EMT.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},336302,1790098538,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,115,120,123,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":112,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":113,"slug":114},8,30,"research-report",{"id":116,"doc_module":4,"doc_module_name":25,"category_name":117,"show_sort_weight":118,"slug":119},9,"Religion & Spirituality",20,"religion-spirituality",{"id":118,"doc_module":4,"doc_module_name":25,"category_name":121,"show_sort_weight":118,"slug":122},"World Cup","world-cup",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":55,"slug":125},"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":112,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":145,"preview_page_count":33,"preview_urls":146},4398048949847,"https://ap-avatar.wpscdn.com/avatar/400002536579ef2da7f?_k=1778318612642679267","DOI: 10.1111/crj.13770  \nORIGINAL ARTICL E  \nZEB1-AS1 mediates bone metastasis through targeting miR-320b/BMPR1A axis in lung cancer  \nNianxi Tan 1 | Junyi Tang 1 | Guang Chen 1 | Weilin Jiang 1 | Zhiqin Liu 2   \n1Department of Cardiothoracic Vascular Surgery, Zhuzhou Hospital Affiliated to Xiangya School of Medicine, Central South University, Zhuzhou, Hunan, China  \n2Department of Orthopedics, Zhuzhou Hospital Affiliated to Xiangya School of Medicine, Central South University, Zhuzhou, Hunan, China  \nCorrespondence  \nZhiqin Liu, Department of Orthopedics, Zhuzhou Hospital Affiliated to Xiangya School of Medicine, Central South University, No.116 Changjiang Road (South), Tianyuan District, Zhuzhou, Hunan 412007, China.  \nEmail: [liuzhiqin0211@163.com](liuzhiqin0211@163.com)  \nFunding information Not applicable.  \nAbstract  \nObjective: This study aimed to explore the role and regulatory mechanism of lncRNA ZEB1-AS1 in lung cancer.  \nMethods: The expression of ZEB1-AS1 and miR-320b was determined by qRT-PCR. Cell viability, proliferation migration, and invasion were assessed using the CCK-8, colony-forming, and Transwell assay. EMT markers were quantified using western blot. The growth of subcutaneous tumor growth and metastatic bone tumors was evaluated in mouse model of lung cancer. Additionally, metastatic bone tumors were examined using H&E staining.  \nResults: ZEB1-AS1 expression was upregulated, while miR-320b levels were downregulated in lung cancer. Knockdown of ZEB1-AS1 resulted in a significant suppression of cell viability, proliferation, migration, invasion, and EMT in A549 cells. Furthermore, we confirmed the targeting relationship between ZEB1-AS1 and miR-320b, as well as between miR-320b and BMPR1A. Our findings suggested that ZEB1-AS1 regulated cell viability, proliferation, migration, and invasion, as well as EMT, in lung cancer cells by targeting the miR-320b/BMPR1A axis. Moreover, our in vivo experiments confirmed that ZEB1-AS1 mediated bone metastasis through targeting miR-320b/BMPR1A axis in mice with lung cancer. Conclusion: ZEB1-AS1 mediated bone metastasis through targeting miR- 320b/BMPR1A axis in lung cancer.  \nKEYWORDS  \nbone metastasis, lung cancer, miR-320b, ZEB1-AS1  \n1 | INTRODUCTION  \nLung cancer is a prevalent malignant tumor worldwide, with bone metastasis being one of the most common sites for metastasis.1 Recent data show that up to 30%–40% of lung cancer patients may progress to bone metastasis, which can result in bone pain, fracture, spinal instability, and nerve compression.2 Radiation therapy is commonly used in the treatment for lung cancer patients with bone  \nmetastasis. However, these patients with bone metastasis have a relatively lower 1-year survival rate of around 40%–50% .3 Therefore, it is of great significance to investigate the molecular mechanism underlying bone metastasis and identify potential therapeutic targets for bone metastasis in lung cancer.  \nLong noncoding RNAs (lncRNAs) are a class of RNA molecules longer than 200 nucleotides that interact with DNA, RNA, and proteins to modulate gene  \nThis is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.  \n© 2024 The Authors. The Clinical Respiratory Journal published by John Wiley & Sons Ltd.  \nexpression. In lung cancer, lncRNAs are involved in diverse biological functions, such as cell proliferation, invasion, and metastasis. As reported, the inhibition of lncRNA IGFBP4-1 suppressed cell proliferation, induced apoptosis and regulated energy metabolism in lung cancer cells.4 Another study by Meng et al revealed that overexpression of lncRNA RMRP promoted cell proliferation, colony formation, and invasion by targeting miR- 206 in lung adenocarcinoma cell lines.5 Additionally, elevated expression of ZEB1-AS1 was observed in non-small cell lung cancer (NSCLC), and silencing ZEB1-AS1 re","cbCaie7ee6ZHF24f","https://ap.wps.com/l/cbCaie7ee6ZHF24f","pdf",7249775,11,"English","# Abstract\n## Objective\n## Methods\n## Results\n## Conclusion\n# Introduction\n## Lung cancer and bone metastasis\n## Roles of lncRNAs and ZEB1-AS1\n## Roles of miRNAs and miR-320b\n## BMPR1A in bone biology and metastasis","[{\"question\":\"What is the main objective of this study?\",\"answer\":\"To explore the role and regulatory mechanism of lncRNA ZEB1-AS1 in lung cancer–related bone metastasis.\"},{\"question\":\"How were ZEB1-AS1 and miR-320b levels measured?\",\"answer\":\"ZEB1-AS1 and miR-320b expression were determined by qRT-PCR.\"},{\"question\":\"What key mechanism links ZEB1-AS1 to bone metastasis?\",\"answer\":\"ZEB1-AS1 targets miR-320b and regulates BMPR1A through the miR-320b/BMPR1A axis, influencing cell viability, proliferation, migration, invasion, and EMT.\"}]","ZEB1-AS1 mediates bone metastasis through targeting miR-320b/BMPR1A axis in lung cancer | PDF",1790014472,28,[147,151,155,159],{"page_no":22,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/6c2ce19d37a9a0adb7ea706b1107d3df.webp",983,1291,{"page_no":26,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/b50bc8c2de33d00c32caec9c367b7b9c.webp",982,1290,{"page_no":30,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/7f14c82a2cb9576db3e694e4466c30b9.webp",981,1289,{"page_no":33,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/68c62fe8d3fe162a58371f6753c31f25.webp",980,1287]